Pivotal Therapeutics Inc. reported earnings results for the full year ended December 31, 2014. For the twelve months ended December 31, 2014 the Company reported a loss of CAD 5.4 million, or CAD 0.06 per common share, compared with a loss of CAD 3.0 million, or CAD 0.04 per common share for the twelve months ended December 31, 2013. Sales for the three and twelve months ended December 31, 2014 are CAD 107,728 and CAD 306,596 respectively as compared to CAD 75,859 and CAD 303,530 for the three and twelve months ended December 31, 2013.

While annual sales increased slightly compared to the previous year, fourth quarter sales achieved an increase of 42% compared to the previous year.